Overview Of Digital Breast Tomosynthesis (DBT) System Market
Digital breast tomosynthesis (DBT) is a 3D breast imaging technique built on full field digital mammography technology. DBT systems create multiple projection images of the breasts obtained from different angles of the rotating X-Ray tube at a low radiation dose through the compressed breast. Images are reconstructed into multiple slices of 1mm thickness and viewed on a dedicated monitor approved for tomosynthesis. This minimizes the impact of tissue superimposition resulting in better visualization of the internal structures. Conventionally, breast screening was performed step by step, starting with full-field digital mammography (FFDM or 2D mammography) followed by digital breast tomosynthesis (3D mammography) or breast Magnetic Resonance Imaging (MRI). FFDM is considered the gold standard in breast cancer screening. However, with the advent of DBT technology, it is slowly being replaced. DBT is frequently used as an adjunct technique with FFDM. Research and studies are being undertaken to consider DBT as a primary screening tool, particularly in patients with dense breasts. 3D mammography has proven to be better than 2D mammography in multiple clinical trials, which has led to an increase in its adoption. Combination of 2D and 3D mammography has become the new standard of care since 3D mammography compliments conventional 2D mammography. The purpose of our study was to comprehensively characterize the dosimetrist properties of a clinical DBT system for the acquisition of mammographic and tomosynthesis images. The new market research report Digital Breast Tomosynthesis (DBT) System Market to its huge collection of research reports. Digital Breast Tomosynthesis (DBT) System market and delivers a comprehensive individual analysis on the top companies, including Hologic, GE Healthcare, Siemens, I.M.S., PLANMED OY, XinRay Systems, FUJIFILM
The global Digital Breast Tomosynthesis (DBT) System market is estimated to be valued at USDXX Million in the year 2028, growing at a CAGR of XX% in the period 2021 to 2028.
The Digital Breast Tomosynthesis (DBT) System market report offers in-depth and extensive analysis of the factors affecting Market Dynamics, Distribution Channel, Product type, and geography, emerging technological trends, market challenges, recent industrial policies, and market size, revenue share and detailed forecasts during 2021-2028. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the revenue forecasts for global, regional and country levels.
Key Companies
Hologic
GE Healthcare
Siemens
I.M.S.
PLANMED OY
XinRay Systems
FUJIFILM
Market Product Type Segmentation
2D Digital Mammography Technology
3D Digital Mammography Technology
Market by Application Segmentation
Hospitals
Diagnostic Centers
Others
By Region
Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America [United States, Canada, Mexico]
Middle East & Africa [GCC, North Africa, South Africa]
South America [Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the size of occupied by the prominent leaders for the forecast period, 2021 to 2028?
• What will be the share and the growth rate of the Digital Breast Tomosynthesis (DBT) System market during the forecast period?
• What are the future prospects for the Digital Breast Tomosynthesis (DBT) System industry in the coming years?
• Which trends are likely to contribute to the development rate of the industry during the forecast period, 2021 to 2028?
• What are the future prospects of the Digital Breast Tomosynthesis (DBT) System industry for the forecast period, 2021 to 2028?
• Which companies are dominating the competitive landscape across different region and what strategies have they applied to gain a competitive edge?
• What are the major factors responsible for the growth of the market across the different regions?
• What are the challenges faced by the companies operating in the Digital Breast Tomosynthesis (DBT) System market?
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.